– UK, London – Medcaw Investments Plc (LON: MCI), a SPAC, today announced the appointment of Charlie Wood and Marcus Yeoman to its Board as Non-executive Directors with immediate effect.
The company also announced that Daniel Maling and Fungai Ndoro have stepped down from the Board to focus on other projects.
About Charlie Wood
Charlie Wood is a highly experienced senior corporate finance executive with wide-ranging international and capital markets experience. Mr. Wood is a Partner of Orana Corporate LLP, a London-based FCA-regulated corporate advisory and accounting practice working with innovative fast growth companies. In addition, Mr. Wood holds various non-executive directorships in listed and private companies across natural resources, technology, and FMCG.
About Marcus Yeoman
Marcus Yeoman is the Chairman and Non-Executive director number of private companies which have engaged him principally to assist them with their growth strategies. His early career started with the formation of three companies in IT infrastructure and distribution, after which he moved into small company broking and corporate work with Rathbone Stockbrokers Limited and Cheviot Capital (Nominees) Limited. In 2003, Marcus established Springtime Consultants Ltd and has been acting as a consultant or Non-Executive Director to several listed companies and SME ventures for over 20 years.
For more information: https://medcaw-invest.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.